MAP2K1 and craniosynostosis: To evaluate the effects of the treatment with the MEK1/2 U0126 and Exportin KPT-330 inhibitors on Erf-related craniosynostosis, microCT scans of the skulls were examined and visually evaluated at the end of the treatment period (Supplementary Figure S4).